Figure 1From: Treatment satisfaction, adherence and behavioral assessment in patients de – escalating from natalizumab to interferon beta Assessment of treatment satisfaction at month six and at year 1 of study in natalizumab (NTZ group) [dotted line] and interferon (IFN B 1B group) [continuous line]. Back to article page